Renal effects and safety between Asian and non‐Asian chronic kidney disease and type 2 diabetes treated with nonsteroidal mineralocorticoid antagonists

Documenti analoghi

• The effect of the endothelin receptor antagonist atrasentan on insulin resistance in phenotypic clusters of patients with type 2 diabetes and chronic kidney disease
  di: Johannes David Smeijer, et al.
  Pubblicazione: (2024)
• Management of diabetes in people with advanced chronic kidney disease
  di: Tahseen A. Chowdhury, et al.
  Pubblicazione: (2024)
• Comparative efficacy and safety of Glucagon‐like pepetide‐1 receptor agonists with metformin in Asian versus non‐Asian patients with type 2 diabetes: A systematic review and meta‐analysis
  di: Wenxuan Li, et al.
  Pubblicazione: (2025)
• Impact of non‐alcoholic fatty liver disease and fibrosis on mortality and kidney outcomes in patients with type 2 diabetes and chronic kidney disease: A multi‐cohort longitudinal study
  di: Lijun Zhao, et al.
  Pubblicazione: (2024)
• Cardiovascular disease risk prediction and profiling among Asian Indians with young‐onset type 1 and type 2 diabetes
  di: Sengottuvelu Aswath Krishna, et al.
  Pubblicazione: (2025)